Diabetes 51:3211-3219, 2002
© 2002 by the American Diabetes Association, Inc.
Uncoupling Protein 2 Knockout Mice Have Enhanced Insulin Secretory Capacity After a High-Fat Diet
Jamie W. Joseph1,
Vasilij Koshkin1,
Chen-Yu Zhang2,
Jing Wang1,
Bradford B. Lowell2,
Catherine B. Chan3, and
Michael B. Wheeler1
1 Departments of Medicine and Physiology, University of Toronto, Ontario, Canada
2 Division of Endocrinology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts
3 Department of Anatomy and Physiology, Atlantic Veterinary College, University of Prince Edward Island, Prince Edward Island, Canada
Uncoupling protein 2 (UCP2) may act as an important regulator of insulin secretion. In this study, ß-cell function in UCP2-deficient mice was examined after a 45% high-fat diet (HFD) to assess its role during the development of diet-induced type 2 diabetes. HFD-fed UCP2 (-/-) mice have lower fasting blood glucose and elevated insulin levels when compared with wild-type (WT) mice. UCP2 (-/-) mice also have enhanced ß-cell glucose sensitivity compared with WT mice after HFD, a result that is due in part to the deterioration of glucose responsiveness in WT mice. HFD-fed UCP2 (-/-) mice have increased insulin secretory capacity as a result of increased pancreatic ß-cell mass and insulin content per islet. Islets from WT mice exposed to 0.5 mmol/l palmitate for 48 h have significantly reduced mitochondrial membrane potential, ATP concentrations, and glucose responsiveness compared with UCP2 (-/-) islets, suggesting that elevated UCP2 in WT mice increases proton leak and decreases mitochondrial ATP production. Highly increased carnitine palmitoyl transferase-1 gene expression in UCP2 (-/-) mice is suggestive of enhanced fatty acid oxidizing capacity, particularly after HFD stress. These results further establish UCP2 as a component in glucose sensing and suggest a possible new aspect of UCP2 function during the progression of type 2 diabetes.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. D. Wikstrom, S. M. Katzman, H. Mohamed, G. Twig, S. A. Graf, E. Heart, A. J.A. Molina, B. E. Corkey, L. M. de Vargas, N. N. Danial, et al.
{beta}-Cell Mitochondria Exhibit Membrane Potential Heterogeneity That Can Be Altered by Stimulatory or Toxic Fuel Levels
Diabetes,
October 1, 2007;
56(10):
2569 - 2578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Olofsson, S. Collins, M. Bengtsson, L. Eliasson, A. Salehi, K. Shimomura, A. Tarasov, C. Holm, F. Ashcroft, and P. Rorsman
Long-Term Exposure to Glucose and Lipids Inhibits Glucose-Induced Insulin Secretion Downstream of Granule Fusion With Plasma Membrane
Diabetes,
July 1, 2007;
56(7):
1888 - 1897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Chevillotte, M. Giralt, B. Miroux, D. Ricquier, and F. Villarroya
Uncoupling Protein-2 Controls Adiponectin Gene Expression in Adipose Tissue Through the Modulation of Reactive Oxygen Species Production
Diabetes,
April 1, 2007;
56(4):
1042 - 1050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. T. De Souza, E. P. Araujo, L. F. Stoppiglia, J. R. Pauli, E. Ropelle, S. A. Rocco, R. M. Marin, K. G. Franchini, J. B. Carvalheira, M. J. Saad, et al.
Inhibition of UCP2 expression reverses diet-induced diabetes mellitus by effects on both insulin secretion and action
FASEB J,
April 1, 2007;
21(4):
1153 - 1163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nakano, Y. Inada, H. Masuzaki, T. Tanaka, S. Yasue, T. Ishii, N. Arai, K. Ebihara, K. Hosoda, K. Maruyama, et al.
Bezafibrate regulates the expression and enzyme activity of 11beta-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes
Am J Physiol Endocrinol Metab,
April 1, 2007;
292(4):
E1213 - E1222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kashemsant and C. B Chan
Impact of uncoupling protein-2 overexpression on proinsulin processing
J. Mol. Endocrinol.,
December 1, 2006;
37(3):
517 - 526.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C Saleh, M. B Wheeler, and C. B Chan
Endogenous islet uncoupling protein-2 expression and loss of glucose homeostasis in ob/ob mice.
J. Endocrinol.,
September 1, 2006;
190(3):
659 - 667.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T S McQuaid, M C Saleh, J W Joseph, A Gyulkhandanyan, J E Manning-Fox, J D MacLellan, M B Wheeler, and C B Chan
cAMP-mediated signaling normalizes glucose-stimulated insulin secretion in uncoupling protein-2 overexpressing {beta}-cells.
J. Endocrinol.,
September 1, 2006;
190(3):
669 - 680.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-T. T. Nguyen, P. Tajmir, C. H. Lin, N. Liadis, X.-D. Zhu, M. Eweida, G. Tolasa-Karaman, F. Cai, R. Wang, T. Kitamura, et al.
Essential Role of Pten in Body Size Determination and Pancreatic {beta}-Cell Homeostasis In Vivo
Mol. Cell. Biol.,
June 15, 2006;
26(12):
4511 - 4518.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sanchez-Blanco, Y.-W. C. Fridell, and S. L. Helfand
Involvement of Drosophila Uncoupling Protein 5 in Metabolism and Aging
Genetics,
March 1, 2006;
172(3):
1699 - 1710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Oberkofler, K. Klein, T. K. Felder, F. Krempler, and W. Patsch
Role of Peroxisome Proliferator-Activated Receptor-{gamma} Coactivator-1{alpha} in the Transcriptional Regulation of the Human Uncoupling Protein 2 Gene in INS-1E Cells
Endocrinology,
February 1, 2006;
147(2):
966 - 976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Toyoshima, O. Gavrilova, S. Yakar, W. Jou, S. Pack, Z. Asghar, M. B. Wheeler, and D. LeRoith
Leptin Improves Insulin Resistance and Hyperglycemia in a Mouse Model of Type 2 Diabetes
Endocrinology,
September 1, 2005;
146(9):
4024 - 4035.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wang, G. Kouri, and C. B. Wollheim
ER stress and SREBP-1 activation are implicated in {beta}-cell glucolipotoxicity
J. Cell Sci.,
September 1, 2005;
118(17):
3905 - 3915.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Yu, D. R. Jacobs Jr, P. J. Schreiner, M. D. Gross, M. W. Steffes, and M. Fornage
The Uncoupling Protein 2 Ala55Val Polymorphism Is Associated with Diabetes Mellitus: The CARDIA Study
Clin. Chem.,
August 1, 2005;
51(8):
1451 - 1456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Fariss, C. B. Chan, M. Patel, B. Van Houten, and S. Orrenius
ROLE of MITOCHONDRIA in TOXIC OXIDATIVE STRESS
Mol. Interv.,
April 1, 2005;
5(2):
94 - 111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. B. Lowell and G. I. Shulman
Mitochondrial Dysfunction and Type 2 Diabetes
Science,
January 21, 2005;
307(5708):
384 - 387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Joseph, V. Koshkin, M. C. Saleh, W. I. Sivitz, C.-Y. Zhang, B. B. Lowell, C. B. Chan, and M. B. Wheeler
Free Fatty Acid-induced {beta}-Cell Defects Are Dependent on Uncoupling Protein 2 Expression
J. Biol. Chem.,
December 3, 2004;
279(49):
51049 - 51056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Remedi, Joseph. C. Koster, K. Markova, S. Seino, T. Miki, B. L. Patton, M. L. McDaniel, and C. G. Nichols
Diet-Induced Glucose Intolerance in Mice With Decreased {beta}-Cell ATP-Sensitive K+ Channels
Diabetes,
December 1, 2004;
53(12):
3159 - 3167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Heron-Milhavet, M. Haluzik, S. Yakar, O. Gavrilova, S. Pack, W. C. Jou, A. Ibrahimi, H. Kim, D. Hunt, D. Yau, et al.
Muscle-Specific Overexpression of CD36 Reverses the Insulin Resistance and Diabetes of MKR Mice
Endocrinology,
October 1, 2004;
145(10):
4667 - 4676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. MacDonald, J. W. Joseph, D. Yau, J. Diao, Z. Asghar, F. Dai, G. Y. Oudit, M. M. Patel, P. H. Backx, and M. B. Wheeler
Impaired Glucose-Stimulated Insulin Secretion, Enhanced Intraperitoneal Insulin Tolerance, and Increased {beta}-Cell Mass in Mice Lacking the p110{gamma} Isoform of Phosphoinositide 3-Kinase
Endocrinology,
September 1, 2004;
145(9):
4078 - 4083.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Poitout
{beta}-Cell Lipotoxicity: Burning Fat into Heat?
Endocrinology,
August 1, 2004;
145(8):
3563 - 3565.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yamashita, K. Eto, Y. Okazaki, S. Yamashita, T. Yamauchi, N. Sekine, R. Nagai, M. Noda, and T. Kadowaki
Role of Uncoupling Protein-2 Up-Regulation and Triglyceride Accumulation in Impaired Glucose-Stimulated Insulin Secretion in a {beta}-Cell Lipotoxicity Model Overexpressing Sterol Regulatory Element-Binding Protein-1c
Endocrinology,
August 1, 2004;
145(8):
3566 - 3577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D'Adamo, L. Perego, M. Cardellini, M. A. Marini, S. Frontoni, F. Andreozzi, A. Sciacqua, D. Lauro, P. Sbraccia, M. Federici, et al.
The -866A/A Genotype in the Promoter of the Human Uncoupling Protein 2 Gene Is Associated With Insulin Resistance and Increased Risk of Type 2 Diabetes
Diabetes,
July 1, 2004;
53(7):
1905 - 1910.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Ashcroft and P. Rorsman
Type 2 diabetes mellitus: not quite exciting enough?
Hum. Mol. Genet.,
April 1, 2004;
13(suppl_1):
R21 - R31.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sasahara, M. Nishi, H. Kawashima, K. Ueda, S. Sakagashira, H. Furuta, E. Matsumoto, T. Hanabusa, H. Sasaki, and K. Nanjo
Uncoupling Protein 2 Promoter Polymorphism -866G/A Affects Its Expression in {beta}-Cells and Modulates Clinical Profiles of Japanese Type 2 Diabetic Patients
Diabetes,
February 1, 2004;
53(2):
482 - 485.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. B. Chan, M. C. Saleh, V. Koshkin, and M. B. Wheeler
Uncoupling Protein 2 and Islet Function
Diabetes,
February 1, 2004;
53(90001):
S136 - 142.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Teshima, M. Akao, S. P. Jones, and E. Marban
Uncoupling Protein-2 Overexpression Inhibits Mitochondrial Death Pathway in Cardiomyocytes
Circ. Res.,
August 8, 2003;
93(3):
192 - 200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kim, M. Haluzik, Z. Asghar, D. Yau, J. W. Joseph, A. M. Fernandez, M. L. Reitman, S. Yakar, B. Stannard, L. Heron-Milhavet, et al.
Peroxisome Proliferator-Activated Receptor-{alpha} Agonist Treatment in a Transgenic Model of Type 2 Diabetes Reverses the Lipotoxic State and Improves Glucose Homeostasis
Diabetes,
July 1, 2003;
52(7):
1770 - 1778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Koshkin, X. Wang, P. E. Scherer, C. B. Chan, and M. B. Wheeler
Mitochondrial Functional State in Clonal Pancreatic {beta}-Cells Exposed to Free Fatty Acids
J. Biol. Chem.,
May 23, 2003;
278(22):
19709 - 19715.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|